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ABSTRACT Diverse bacteria, including several Pseudomonas species, produce a class of redox-active metabolites called
phenazines that impact different cell types in nature and disease. Phenazines can affect microbial communities in both positive
and negative ways, where their presence is correlated with decreased species richness and diversity. However, little is known
about how the concentration of phenazines is modulated in situ and what this may mean for the fitness of members of the com-
munity. Through culturing of phenazine-degrading mycobacteria, genome sequencing, comparative genomics, andmolecular
analysis, we identified several conserved genes that are important for the degradation of three Pseudomonas-derived phenazines:
phenazine-1-carboxylic acid (PCA), phenazine-1-carboxamide (PCN), and pyocyanin (PYO). PCA can be used as the sole carbon
source for growth by these organisms. Deletion of several genes inMycobacterium fortuitum abolishes the degradation pheno-
type, and expression of two genes in a heterologous host confers the ability to degrade PCN and PYO. In cocultures with
phenazine producers, phenazine degraders alter the abundance of different phenazine types. Not only does degradation support
mycobacterial catabolism, but also it provides protection to bacteria that would otherwise be inhibited by the toxicity of PYO.
Collectively, these results serve as a reminder that microbial metabolites can be actively modified and degraded and that these
turnover processes must be considered when the fate and impact of such compounds in any environment are being assessed.
IMPORTANCE Phenazine production by Pseudomonas spp. can shape microbial communities in a variety of environments rang-
ing from the cystic fibrosis lung to the rhizosphere of dryland crops. For example, in the rhizosphere, phenazines can protect
plants from infection by pathogenic fungi. The redox activity of phenazines underpins their antibiotic activity, as well as provid-
ing pseudomonads with important physiological benefits. Our discovery that soil mycobacteria can catabolize phenazines and
thereby protect other organisms against phenazine toxicity suggests that phenazine degradation may influence turnover in situ.
The identification of genes involved in the degradation of phenazines opens the door to monitoring turnover in diverse environ-
ments, an essential process to consider when one is attempting to understand or control communities influenced by phenazines.
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Pseudomonas spp. are important biocontrol agents that pro-duce a variety of secreted metabolites that suppress disease
in the rhizosphere (1–4). Of these metabolites, phenazines are
an important subclass. Phenazines have long been studied due
to their antibiotic activities against diverse cell types as well as
their beneficial physiological roles for their producers (5). In
agricultural settings, the production of phenazines—particu-
larly phenazine-1-carboxylic acid (PCA) and phenazine-1-
carboxamide (PCN)—is thought to protect plants from colo-
nization and infection by pathogenic fungi (1–3). Phenazines
accumulate in the rhizosphere of dryland cereals, where they
have a half-life of 3.4 days (2). In addition to the rhizosphere,
phenazines are present and active in other environmental and
clinical contexts, such as crude oil and the lungs of patients
with the genetic disorder cystic fibrosis (CF) (6–8); however,
their turnover has not been measured in any of these systems.
While the relatively short half-life of phenazines in the rhizo-
sphere suggests that there are active mechanisms of removal, it
is unclear what they are.
Many natural phenazine compounds with a common nitrogen-
heterocyclic core have been described (Fig. 1A). Pseudomonas spp.
and other bacteria produce several phenazine derivatives with
diverse properties (9). The most abundant phenazines in
laboratory-grown Pseudomonas aeruginosa culture are PCA, PCN,
and pyocyanin (PYO). PCA is the precursor from which all other
phenazines are derived, PYO is produced by the action of two
enzymes (PhzM and PhzS) that modify PCA, and PCN is gener-
ated from PCA by the action of PhzH (10). P. aeruginosa can also
produce 1-hydroxyphenazine through the action of PhzS.
Phenazines benefit producing organisms in a variety of ways. In
P. aeruginosa, phenazines are involved in anaerobic survival, iron
acquisition, signaling, and biofilm development (11–14). How-
ever, the redox properties of phenazines are harmful to other bac-
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teria and eukaryotic organisms that are often found in association
with Pseudomonas spp. (15–17).
Phenazine toxicity differs depending on the phenazine type
and can change under various environmental conditions. For ex-
ample, Caenorhabditis elegans is more sensitive to PCA than PYO
at acidic pH, but the opposite is true at alkaline pH (15).
Phenazines can cause toxicity by producing reactive oxygen spe-
cies (ROS) and interfering with the respiratory electron transport
chain (16, 17). While defense against the toxic effects of
phenazines is generally thought to involve the induction of ROS
defense systems, the capacity to degrade or transform phenazines,
including PCA and PCN, has also been demonstrated (18–20). A
recent study showed changes to phenazines in mixed communi-
ties, where diffusion of phenazines between colonies of P. aerugi-
nosa and Aspergillus fumigatus results in several metabolic trans-
formations (but not removal) of the phenazines (21). Yet, in
analogy to what has been shown for acyl-homoserine lactone
quorum-sensing signal degradation (22, 23), it is important to
consider turnover processes in addition to chemical modifications
when one is seeking to understand the fate of phenazines in the
environment.
While the capacity to alter or degrade phenazines has been
demonstrated by microbes associated with Pseudomonas spp. in
natural communities (18–21), the genes responsible for this activ-
ity have been unknown. Here, we isolated phenazine-degrading
organisms and identified genes involved in the degradation of
three Pseudomonas-derived phenazines. We used these findings to
explore the effects of phenazine degradation on phenazine pro-
ducers (pseudomonads) and degraders (mycobacteria) and to de-
termine whether phenazine degradation can play a protective role
for other, phenazine-sensitive organisms. Our findings suggest
that the interactions between phenazines and phenazine degrad-
ers have the potential to tune the concentrations of different
phenazine types, and if phenazine degradation is active in situ, it
would be expected to impact microbial community structure.
RESULTS
Isolation of PCA-degrading organisms. PCA is the precursor of
all phenazines produced by Pseudomonas spp. (9, 10). Therefore,
we reasoned that the ability to degrade PCA would be common
among organisms capable of degrading Pseudomonas-derived
phenazines. Soil was collected from 16 locations around the Cal-
ifornia Institute of Technology campus and the nearby San Ga-
briel mountains. Samples from six sites yielded isolates capable of
growing in medium with 2.5 mM PCA as the sole source of carbon
and energy (Fig. 1B). Among the isolates that were verified to
degrade PCA, all had similar colony morphology; thus, one isolate
from each site was randomly selected for follow-up studies. Partial
16S rRNA gene sequences were determined for each isolate and
phylogenetic trees were constructed. PCA-degrading organisms
grouped with two members of the genus Mycobacterium, Myco-
bacterium fortuitum (GenBank accession number NR_118883) and
Mycobacterium septicum (accession number NR_042916), with
99% sequence identity (Fig. 1C). Strains CT6 (M. fortuitum-
like) and DKN1213 (M. septicum-like) were chosen as representa-
tive strains for further study.
Strains CT6 and DKN1213 can additionally degrade PYO.
While PCA is produced by all pseudomonads capable of
phenazine production, PYO is produced only by P. aeruginosa and
is the best-studied phenazine due to its clinical relevance. We
therefore sought to determine if our isolates were capable of de-
grading PYO. Because PYO is poorly soluble in aqueous solutions
at circumneutral pH, we monitored PYO degradation using mi-
cromolar— but physiologically relevant (24)— concentrations
with cultures grown in 10% LB-Tw (lysogeny broth with 0.05%
Tween 80) medium. Both CT6 and DKN1213 were capable of
FIG 1 Isolation, identification, and degradation phenotype of phenazine-degrading bacteria. (A) Structure of phenazines. For PCA, YCOOH; for PCN, Y
CONH2; for PYO, XCH3 and YOH. (B) Growth of representative isolates CT6 and DKN1213 with PCA as a sole source of carbon and energy. P. aeruginosa
and M. smegmatis were both incapable of growth under this condition. (C) 16S rRNA gene dendrogram of various phenazine-degrading bacteria (red) and close
relatives. Organisms in blue were tested for phenazine degradation but showed no activity. (D) Growth and degradation of PYO by strains CT6 (red) and
DKN1213 (blue) supplied with 10% LB-Tw as a carbon source. Data are averages and standard deviations (SD) for three cultures. Solid lines, PYO concentration;
dashed lines, OD.
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degrading PCA under these conditions. Both strains were addi-
tionally capable of degrading PYO from a starting concentration
of 200 M to a final concentration of less than 20 M (the detec-
tion limit of our assay) (Fig. 1D) with a concomitant change of the
medium from blue to colorless. No change in medium color or
measured PYO was observed for the close relative Mycobacterium
smegmatis (see Fig. S1 in the supplemental material).
Genome sequence of strain CT6 and identification of candi-
date dioxygenases involved in PCA degradation. Phenazines are
polycyclic, aromatic, nitrogen-containing heterocycles (Fig. 1A);
therefore, we hypothesized that the genes responsible for their
degradation likely encode dioxygenases, a family of enzymes
known to break down aromatics. Several observations lend cre-
dence to this notion. First, because the only source of carbon in
PCA that is sufficiently reduced to support growth is bound within
the ring, it must be cleaved; the carboxylate moiety alone cannot
support growth (Fig. 1A). Second, previous studies of the PCA
degradation pathway in Sphingomonas wittichii strain DP58, the
only other known PCA degrader, demonstrated that ring cleavage
is essential for PCA catabolism (25). Furthermore, in our cultures,
we never observed the accumulation of the unsubstituted core
phenazine molecule, despite the fact that our mycobacteria can
degrade this molecule (see Fig. S2 in the supplemental material);
its absence strongly suggests that the core phenazine ring is
cleaved. Finally, the fact that our mycobacteria can also use PCA as
a sole nitrogen source (see Fig. S3 in the supplemental material)
further indicates that ring cleavage must occur in order for nitro-
gen to be liberated from PCA (Fig. 1A). Accordingly, we focused
on identifying putative dioxygenase enzymes that might catalyze
PCA degradation.
The genome of S. wittichii strain DP58 has been sequenced and
contains 91 predicted dioxygenase genes, though none have been
identified as important for PCA degradation (19, 26). We sought
to identify candidate dioxygenase genes for PCA degradation by
comparative genomic analysis of S. wittichii DP58 and one of the
phenazine-degrading mycobacteria described here. The genome
of strain CT6 was sequenced to completion using the PacBio
single-molecule, real-time (SMRT) genome sequencing technol-
ogy. The strain CT6 genome is 6.25 Mbp and contains no plas-
mids. There are a predicted 6,051 protein-encoding genes accord-
ing to the RAST (Rapid Annotation using Subsystem Technology)
server, and the genome contains 35 to 47 dioxygenase genes as
annotated by RAST or the Bacterial Annotation System (BASys)
pipelines, respectively (27–29). Reciprocal best BLAST analysis of
annotated dioxygenase genes was performed between S. wittichii
strain DP58 and strain CT6 (PCA degraders) or M. smegmatis
mc2-155 and strain CT6 to identify genes present in both PCA-
degrading organisms but absent from M. smegmatis. This
identified three predicted dioxygenase genes—XA26_16830,
XA26_16860, and XA26_16890 —that are co-oriented in an ~10-
kbp chromosomal locus in strain CT6 (Table 1; also, see Ta-
ble S1 in the supplemental material). Because the same set of genes
is present in both sequenced PCA-degrading organisms, we hy-
pothesized that these genes would be regulated specifically by
phenazines. Quantitatve reverse transcription-PCR (qRT-PCR)
analysis of the expression of putative dioxygenase genes in strain
CT6 demonstrated that these three genes, as well as a nearby
fourth gene predicted to encode a dioxygenase (XA26_16730), are
highly induced in the presence of phenazines (Fig. 2A). mRNA
abundance for these genes was increased1,000-fold in the pres-
ence of both PCA and PYO after a 3-h exposure but not in the
presence of 9,10-anthraquinone-2,6-disulfonate (AQDS) or
methylene blue (MB), two other 3-ringed, aromatic, redox-active
molecules (13). AQDS and MB have midpoint redox potentials
that are lower and higher, respectively, than those of phenazines
(13) suggesting that a redox switch is not responsible for increased
expression. The mRNA abundance of two predicted dioxygenase
genes located distantly on the chromosome was unchanged in the
presence of any compounds tested.
Rhodococcus strain JVH1 and M. fortuitum ATCC 6841 are
both capable of degrading phenazines. A comparison of the ge-
nome of CT6 to that of the type strain M. fortuitum ATCC 6841
revealed the presence of the predicted PCA-degrading genes, and
this organism was verified to degrade both PCA and PYO (see
Fig. S1 in the supplemental material). The putative dioxygenases
predicted to be involved in PCA degradation were analyzed in the
Integrated Microbial Genomes/Expert Review (IMG/ER) web
server (30, 31), and Rhodococcus sp. strain JVH1 was also found to
contain these genes (32, 33). Based on their presence, we predicted
that Rhodococcus sp. strain JVH1 would be capable of PCA degra-
dation. When suspended at high density (optical density at 600
nm [OD600] of ~2 to 3), JVH1 degraded 200M PCA to ~50% of
the starting concentration in 48 h—a rate of degradation signifi-
cantly lower than that observed for mycobacteria. No activity was
TABLE 1 Genes important to this studya
CT6 M. fortuitum ATCC 6841 Rhodococcus JVH1 Sphingomonas DP58
XA26 gene no. RAST annotation MFORT gene no. % ID Gene GI no. % ID MSEDRAFT gene no. % ID
16600 3-Hydroxy-4-oxoquinaldine 2,4-dioxygenase 16204 100 00241 32
16610 Salicylate hydroxylase 16209 99 497117731 28 05232 33
16620 Hypothetical protein 16214 99 760099504 38 02403 35
16640 4-Hydroxyphenylacetate 3-monooxygenase 16224 100 396930211 32
16730 Ortho-halobenzoate 1,2-dioxygenase 16269 99 497121742 79 05237 41
16830 2,3-Dihydroxybiphenyl 1,2-dioxygenase 16319 95 497121763 82 04471 52
16860 Large subunit naph/bph dioxygenaseb 16334 100 497121769 89 04467 73
16890 2,3-Dihydroxybiphenyl 1,2-dioxygenase 16349 99 497121775 80 04486 62
16960 Amidase 30529 99 497116141 32 05146 34
16980 Probable oxidoreductase 14347 99 497109126 27 04185 27
16990 Hypothetical protein 14352 99
a An expanded version of this table is presented as Table S1 in the supplemental material. ID, identity.
b naph/bph, naphthalene/biphenyl.
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seen in Rhodococcus sp. strain RHA1, the closest sequenced rela-
tive that lacks the genes of interest (Fig. 2B). No degradation ac-
tivity was observed with PYO for either strain.
Allelic replacement of candidate dioxygenase homologs
fromM. fortuitumATCC6841 abolishes the ability to growwith
PCA as the sole carbon source. The presence of the same putative
dioxygenase genes in all PCA degraders and their phenazine-
specific regulation in strain CT6 strongly suggest an involvement
in PCA degradation. We used mutagenesis to test this hypothesis.
Attempts to genetically manipulate strain CT6 were ineffective,
but a similar approach succeeded in theM. fortuitum type strain. A
recombineering approach was employed to create mutations
in the four putative dioxygenase genes (MFORT_16269, MFORT_
16319, MFORT_16334, and MFORT_16349) (Table 1) (34), and
each gene was replaced with a gentamicin resistance cassette.
Gentamicin-resistant colonies with disruptions in each gene were
streaked onto agar medium with 2.5 mM PCA as the sole carbon
source. None of the mutants grew under these conditions, indi-
cating that the mutated genes are essential for growth with PCA as
a carbon source (Fig. 2C). High-performance liquid chromatog-
raphy (HPLC) analysis of supernatants from cultures grown on
LB medium with 100 M PCA revealed the loss of PCA from
16319::Gmr, 16334::Gmr, and 16349::Gmr strains but not
from the16269::Gmr strain (see Fig. S4 in the supplemental ma-
terial). This suggests that the product of MFORT_16269 is neces-
sary to catalyze PCA degradation, whereas the other genes are
involved in a downstream reaction (these mutants cannot use
PCA as a carbon source [Fig. 2C] but still remove it from culture
supernatants [see Fig. S4 in the supplemental material]). None of
these mutants had a defect in PYO removal.
Notably, only the putative single-subunit, ring-cleavage dioxy-
genase genes, MFORT_16319 and MFORT_16349, could be com-
plemented in trans (see Fig. S5 in the supplemental material). It is
unclear why the putative multisubunit, ring-hydroxylating dioxy-
genase genes MFORT_16269 and MFORT_16334 could not be
complemented, but perhaps these enzymes are nonfunctional
when overexpressed. The position of the gentamicin resistance
cassette on the chromosome was verified by sequencing for each
mutation; however, we cannot rule out the possibility that a
secondary site mutation resulted in the phenotype for the
MFORT_16269 and MFORT_16334 mutants.
RNA-Seq and mutagenesis identifies a small hypothetical
protein that is necessary for PYO degradation. Because the four
predicted dioxygenase genes were expressed specifically in the
presence of phenazines, we took a transcriptome sequencing
(RNA-Seq) approach to identify candidate genes important to
PYO degradation. Strain CT6 was used for RNA-Seq because the
genome of this organism has been closed, whereas the genome of
ATCC 6841 exists as 82 contigs (35). As expected, the genes im-
portant for PCA-dependent growth showed increased mRNA
abundance after a 20-min exposure to either PCA or PYO
(Fig. 3A). In fact, the entire region of the CT6 genome that
shares homology with Rhodococcus sp. strain JVH1 (an organ-
ism that can degrade only PCA) was highly expressed in the
presence of either PCA or PYO. Additionally, genes flanking
this region had increased mRNA abundance and were induced
to a greater extent by PYO.
A mutant lacking the entire ~40-kb region (40kb::Gmr) of
the genome induced by phenazines was constructed in M. for-
tuitum and found to completely lack the ability to degrade
phenazines, including PYO (Fig. 3B). This locus contains genes
for an additional predicted dioxygenase (MFORT_16204
[XA26_16600]) and a monooxygenase (MFORT_16224 [XA26_
16640]) in one of the flanking regions; however, mutants with
mutations in both genes were still capable of PYO degradation
(Fig. 3B). Of note is that 16224::Gmr degrades PYO more
slowly than the wild type (WT), suggesting a possible role in a
downstream reaction in the PYO degradation pathway. A mu-
tant missing a three-gene operon in the other flanking region
(MFORT_14352 to MFORT_30529 [XA26_16990 to XA26_
16960]) lacked the ability to degrade PYO. A single gene mu-
tant lacking MFORT_14352, annotated as a hypothetical pro-
tein, was deficient in PYO degradation; additionally,
expression of this gene in Rhodococcus sp. strain JVH1 allowed
PYO degradation by this strain (see Fig. S6 in the supplemental
material). Therefore, MFORT_14352 is necessary for the first
step of PYO degradation and may be sufficient for the removal
of this phenazine from the medium.
FIG 2 Evidence for the involvement of four putative dioxygenase genes in the
breakdown of PCA. (A) qRT-PCR of genes from cultures exposed to various
redox-active small molecules. Data are normalized internally to rpoA and to a
control with no added small molecule. Data represent at least duplicates, and
error bars show one SD around the mean for triplicate cultures. (B) Phenazine
degradation by Rhodococcus strains JVH1 and RHA1. Data are averages and SD
for three independent cultures. (C) Growth of individual gene mutants with
PCA as a sole carbon source.
Costa et al.
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M. fortuitum alters the phenazine pool in coculture with
Pseudomonas spp. M. fortuitum is ubiquitous and found in envi-
ronments where phenazine-producing pseudomonads are also
present (36, 37). Using a subset of the mutants described above,
we sought to determine whether a mixed culture of M. fortuitum
with a pseudomonad would lead to alterations in the phenazine
pool. M. fortuitum and several mutants were inoculated into LB
medium with P. aeruginosa PA14, and culture supernatants were
analyzed by HPLC after 24 h. The40kb::Gmr mutant was used as
a control to determine the amount of phenazines produced by
PA14 under coculture conditions. The WT M. fortuitum strain
decreased the abundance of both PYO (~50% decreased) and
PCN (~90% decreased) but not PCA in coculture with PA14
(Fig. 4A). This level of phenazine degradation impacted neither
the rate of P. aeruginosa growth nor its transcription of the
phenazine biosynthesis genes. As expected, the PYO degradation
mutant, 14352::Gmr, decreased the abundance of PCN but not
PYO. The mutant30529::Gmr decreased PYO but not PCN, sug-
gesting that MFORT_30529 —annotated as an amidase—may
convert PCN to PCA. In fact, cocultures that are proficient for
PCN degradation seem to have higher PCA concentrations in
their supernatants, supporting this hypothesis (Fig. 4A; also, see
Fig. S6 in the supplemental material). The PCN degradation phe-
notype of 30529::Gmr was assayed in monoculture, and this
strain was confirmed to have a specific defect in the removal of
PCN from culture supernatants (see Fig. S7 in the supplemental
material); additionally, expression of MFORT_30529 in Rhodo-
coccus sp. strain JVH1 conferred the ability to degrade PCN to this
organism (see Fig. S6).
Because M. fortuitum in coculture with PA14 prioritizes PYO
and PCN removal from the medium, to determine whether PCA
could also be degraded in coculture, we mixed M. fortuitum and
FIG 3 Gene expression and mutational analysis of PYO degradation. (A) mRNA abundance of strain CT6 genes after 20-min exposure to PCA or PYO. Values
are given as log2 fold change versus a mock treatment. An ~40-kb region of the genome shows a large change in gene expression in response to phenazines. Strain
CT6 gene numbers are listed on the x axis, with genes on the plus strand listed on the top row and genes on the minus strand listed on the bottom row. Genes
highlighted in red are present in the genome of Rhodococcus strain JVH1 (Table 1; also, see Table S1 in the supplemental material). Blue points represent relative
mRNA abundance after PYO exposure, and orange points correspond to PCA exposure. (B) Growth and PYO degradation characteristics of M. fortuitum
mutants grown in 10% LB-Tw medium supplemented with 200M PYO. All mutants could grow with 10% LB as the carbon source, but only a subset displayed
a defect in PYO degradation. Data are averages and SD for three cultures. RNA-Seq data for the entire chromosome can be found in Dataset S1 in the
supplemental material.
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Pseudomonas fluorescens 2-79, an organism that produces PCA as
its only phenazine. WT M. fortuitum was capable of removing
~50% of the PCA from culture supernatants compared to the
40kb::Gmr control (Fig. 4B). As expected, 16269::Gmr was de-
fective for PCA removal. For unknown reasons,30529::Gmr was
also defective for PCA removal in the coculture condition.
PYO degradation is protective to other organisms in
coculture with M. fortuitum. Alterations in the abundance of
phenazines in cocultures of M. fortuitum and Pseudomonas spp.
demonstrate that phenazine degradation can influence the con-
centration of structurally diverse phenazines in the coculture en-
vironment. Because phenazines can function as antimicrobials
(16, 17), it is ecologically important to consider whether degrada-
tion might impact other members of a microbial community. We
hypothesized that PYO degradation would be protective to organ-
isms that are otherwise susceptible. PYO survival was assayed in
cocultures of M. fortuitum mixed with diverse bacteria that have a
range of sensitivity to different phenazines: Staphylococcus aureus,
Agrobacterium tumefaciens, Shewanella oneidensis, and Escherichia
coli (16, 17, 38, 39). After 24 h of incubation in monoculture in the
presence of 100 M PYO, S. aureus, E. coli, and S. oneidensis were
all inhibited by PYO to various degrees (Fig. 5). In all three cases,
coculture with WT M. fortuitum rescued growth of these organ-
isms, though not always to the same extent as growth in monocul-
ture in the absence of PYO. A PYO degradation mutant provided
no protection. A. tumefaciens was resistant to PYO, consistent
with previous reports (38), and coculture had little effect on this
organism.
DISCUSSION
Phenazines can shape both microbial community composition
and the chemistry of the environment; however, while much is
known about their biosynthesis, regulation and physiological
functions (11–14), little is known about their degradation. Previ-
ously, S. wittichii DP58 was shown to be capable of degrading
PCA, yet the genes catalyzing this process were not identified (25).
Here, we identified genes involved in the degradation of multiple
phenazines in members of the Mycobacterium fortuitum complex.
The identification of conserved degradation genes in mycobacte-
ria not only broadens the phylogenetic diversity of this activity to
include members of both the Proteobacteria and Actinobacteria
phyla it also suggests that the enzymes catalyzing this activity may
be widespread.
Mycobacteria are ubiquitous, and Mycobacterium spp. and
Pseudomonas spp. are commonly reported to be present in the
same types of environments, including soil, crude oil, and the
lungs of patients with CF (6–8). It may thus not be surprising that
one organism has evolved the capacity to utilize an excreted prod-
uct of the other. A common gene cluster that appears to be essen-
tial for PCA degradation is shared between the genomes of M. for-
tuitum ATCC 6841, Rhodococcus sp. strain JVH1, and strain CT6.
Notably, the same four putative dioxygenases display increased
mRNA abundance in strain CT6 in the presence of both PCA and
PYO. Rhodococcus strain JVH1 is incapable of PYO degradation
yet possesses close homologs of each of these genes. This suggests
that PCA and PYO may share a degradation intermediate. In
P. aeruginosa, PYO is produced from PCA via the action of PhzS
and PhzM (10). One possibility is that strains CT6 and DKN1213
first degrade PYO to PCA and that this product leads to the in-
creased mRNA abundance for PCA-specific genes. A second pos-
sibility is that PCA and PYO may be converted to an intermediate
FIG 4 Phenazine degradation by M. fortuitum strains grown in coculture
with Pseudomonas spp. Cocultures were grown for 24 h, and phenazine con-
centrations were measured by HPLC. 40 kb::Gmr is defective in phenazine
degradation, so PYO, PCN, and PCA levels in a coculture with this strain were
arbitrarily set to 100%. (A) Phenazine levels in a coculture between the indi-
cated mutant and P. aeruginosa PA14. (B) PCA levels in a coculture between
the indicated mutant and P. fluorescens 2-79. Data are averages and SD from
three experiments.
FIG 5 PYO degradation protects sensitive organisms. E. coli, S. oneidensis, S. aureus, and A. tumefaciens were plated after coculture with WT M. fortuitum or
14352::Gmr () in the presence of 100M PYO. Survival of these organisms in monoculture with 0 or 100M PYO is included to verify their sensitivity to PYO.
Sensitive organisms had increased cell density after incubation with the WT, suggesting a protective effect for PYO degradation.
Costa et al.
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that is further degraded through the action of MFORT_16269,
MFORT_16319, MFORT_16334, and MFORT_16349 or a subset
of these. A small (162-amino-acid) protein is sufficient to catalyze
PYO degradation, and a predicted amidase is likely required for
the first step in PCN breakdown. An amidase activity suggests that
PCN is first converted to PCA before further breakdown takes
place. Elucidation of the complete pathway(s) of PCA, PCN, and
PYO degradation awaits future research, yet this study provides an
important step in that direction.
What consequences might the degradation of different
phenazines have on Pseudomonas spp.? Though we did not ob-
serve significant phenotypic consequences of phenazine degrada-
tion on P. aeruginosa under standard laboratory growth condi-
tions, it is possible that phenazine degradation may decrease the
fitness of phenazine-producing organisms in natural or engi-
neered environments. Each Pseudomonas-derived phenazine has
unique redox and chemical properties (13, 40) and a distinct im-
pact on the physiology of its producer (9, 41). For example, PYO is
important for biofilm maturation in P. aeruginosa (42), and PCA
rapidly reduces ferric iron, facilitating iron acquisition (12).
Phenazine toxicity to other organisms can benefit Pseudomonas
spp. by inhibiting competitors. Finally, phenazines are terminal
signaling factors in the quorum-sensing network of pseudomon-
ads (14). In many cases, the impact of molecular signals is
concentration dependent, but how degradation influences the ac-
cumulation and fate of bacterial signals is generally poorly char-
acterized. However, as shown by work on acyl-homoserine lac-
tone degradation, the ability to control signal accumulation can
significantly affect the behavior of microbes responsive to that
signal if it is consumed below a certain threshold (22, 23). We thus
speculate that controlling the distribution of phenazines via deg-
radation might similarly attenuate the ability of Pseudomonas spe-
cies to dominate environments where phenazine cycling is bene-
ficial (e.g., hypoxic or anoxic habitats) or provides a competitive
advantage.
Just as the degradation of phenazine metabolites would be pre-
dicted to impact the fitness of phenazine producers, we might also
anticipate a more general effect on ecosystem diversity. P. aerugi-
nosa interactions with plants highlight the potential implications
of this interaction on the outcome of two different fungal infec-
tions. PYO enhances susceptibility of rice to Rhizoctonia solani but
leads to increased resistance to Magnaporthe grisea (43); the pres-
ence of a PYO-degrading organism could significantly alter the
outcome of infection in each of these cases. While there is evidence
of phenazine turnover and degradation in the rhizosphere (2, 19),
phenazines also play important roles in other environments where
these processes have not been measured or observed. The presence
of phenazines is negatively correlated with microbial species rich-
ness in both laboratory enrichment cultures and the lungs of pa-
tients with CF (6–8, 44). What role might natural or stimulated
degradation play in modulating phenazine levels and microbial
community development in these and other contexts? Given that
phenazine degradation can impact the fitness of organisms by
promoting growth and minimizing toxicity, it is temting to spec-
ulate that these activities may be important in natural environ-
ments. Future work will determine whether this is, in fact, the case.
MATERIALS AND METHODS
Strains, media, and growth conditions. Strains used in this study are
listed in Table S2 in the supplemental material. PCA-degrading organisms
were isolated by inoculating 5 ml of PCA medium with 100 mg of soil
collected on and around the California Institute of Technology campus
and growing at 30°C with shaking. PCA medium was composed of mini-
mal medium containing (per liter) KH2PO4 (1.93 g), K2HPO4 (6.24 g),
NaCl (2.5 g), MgSO4 (0.12 g), NH4Cl (0.5 g) and supplemented with PCA
(0.56 g). Trace minerals were also included (45). Cultures were allowed to
grow for 5 to 8 days before transfer to fresh PCA medium. After 3 rounds
of growth in PCA liquid medium, cultures were streaked on plates con-
taining PCA medium amended with 1.5% Bacto agar. After isolation,
strains were routinely grown in lysogeny broth with 0.05% Tween 80
(LB-Tw). PCA and PCN were purchased from Princeton Biomolecular
Research Inc., and PYO was purified from cultures of P. aeruginosa strain
PA14 grown with 40 mM succinate as the sole carbon source using organic
extraction into dichloromethane as described previously (14).
Growth curves were performed in 10% LB-Tw medium supplemented
with 200 M PCA, PYO, or PCN. Cultures were grown to mid-
exponential phase and diluted to an OD of ~0.1 to 0.2 for growth analysis.
Growth curves were carried out in 96-well plate format on a BioTek Syn-
ergy 4 microplate reader (BioTek, Inc.) set to 30°C and medium agitation.
Ninety-six-well plates were sealed with sterile adhesive film to prevent
medium evaporation. OD was monitored at 500 nm; PCA and PCN were
monitored at 370 nm, and PYO was monitored at 310 nm. Standards were
included to calculate the concentrations of each phenazine. PCA and PYO
degradation by Rhodococcus was performed at an OD600 of ~2 to 3. Rho-
dococcus spp. were suspended in 10% LB medium with 200 M PCA or
PYO in a volume of 5 ml. A 500-l portion of culture supernatant was
collected by centrifugation at various time points and analyzed on a plate
reader.
Coculture experiments were carried out in LB with various M. fortui-
tum strains at a starting OD of 0.15. Pseudomonads were inoculated to an
OD of 0.05 and other organisms to 0.001. Cocultures were grown for 24 h
in all cases except for A. tumefaciens (48 h). To test the protective effects of
PYO degradation, 100M PYO was included, and cultures were plated on
LB at the end of growth to enumerate CFU (all organisms formed colonies
in 1 to 2 days versus 3 to 5 days for M. fortuitum, so selective medium was
not necessary). To analyze coculture supernatants, samples were diluted
1:10, sterilized by filtration on a 0.2-m filter and analyzed by HPLC as
described previously (12) using the same method but a flow rate of 950l
min1.
Phylogenetic analysis. 16S rRNA genes were amplified using primers
9bf and 1512uR and sequenced with 9bf and 519uF (46, 47). Relatives
were found using BLAST (http://blast.ncbi.nlm.nih.gov) and collected
for analysis. All phylogenetic analyses were performed using the phylog-
eny.fr web server and further refined using Interactive Tree Of Life (iTOL)
(48–51).
DNAextraction, genome sequencing, gene annotation and analysis.
DNA extraction of strain CT6 was performed using a modified protocol
from (52). Fifty milliliters of mid-exponential-phase culture was har-
vested and stored at80°C before DNA extraction. Pellets were thawed at
80°C for 30 min and suspended in an equal volume of chloroform-
methanol (2:1) for 1 h with periodic shaking at room temperature. This
mix was centrifuged for 20 min at 2,500 g, and the organic and aqueous
phases were discarded without disturbing the cell material. The cell pellet
was dried for 10 min at 55°C, suspended in 550 l of 100 mM Tris
(pH 9.5), and incubated overnight at 37°C with lysozyme (final concen-
tration, 0.5 mg ml1). After lysozyme treatment, SDS (final concentra-
tion, 1%) and proteinase K (final concentration, 0.75 mg ml1) were
added, and the tube was left at 60°C for 1 h with periodic mixing. During
the last 15 min of incubation, 100 l each of 5 M NaCl and cetyltrimeth-
ylammonium bromide (CTAB) solution (10% CTAB solution in 0.7 M
NaCl) was added. DNA was extracted with 1 vol of chloroform-isoamyl
alcohol (24:1), and the aqueous phase was treated with RNase A. RNA-
free DNA was ethanol precipitated and stored at 80°C before se-
quencing.
SMRT sequencing was performed using the Pacific Biosciences RS II
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platform with 10-kb libraries and P5/C3 chemistry using the standard
protocols. The de novo genome assembly, using HGAP v2 (53), resulted in
a single circular contig. The genome of strain CT6 was annotated using
RAST and BASys (27–29). Genomes were analyzed using BLAST
(http://blast.ncbi.nlm.nih.gov) and the Integrated Microbial Genomes/
Expert Review (IMG/ER) web server (https://img.jgi.doe.gov/er/) (26, 30,
31, 35).
RNA extraction, qRT-PCR, and RNA-Seq. To generate material for
qRT-PCR analysis, overnight cultures were diluted 1/50 in LB-Tw and
grown overnight to an OD600 of ~0.3. At this point, PCA, PYO, AQDS, or
MB was added to a final concentration of 200 M. An equivalent volume
of water was added to a set of cultures as a control. After 3 h, cell material
was collected, flash frozen, and stored at 80°C until RNA extraction.
Frozen cell pellets were suspended in 350 l AES buffer (50 mM sodium
acetate [pH 5.3], 10 mM EDTA, 1% SDS) and 350 l acid phenol-
chloroform (5:1; pH 4.5), and 200l glass beads (106m) were added.
Samples were homogenized in an analog Disruptor Genie (Scientific In-
dustries, Inc.) four times for 30-s each with a 30-s interval on ice between
disruptions. Glass beads were removed by centrifugation, and liquid was
transferred to a heavy phase lock tube containing 300l chloroform. The
phase lock tube was centrifuged for 5 min at 12,000  g. The aqueous
phase was extracted with an additional 300l chloroform and transferred
to a microcentrifuge tube containing 40 l 3M sodium acetate (pH 5.2),
and RNA was alcohol precipitated and suspended in 100 l H2O. This
crude RNA extract was cleaned using an RNeasy kit (Qiagen, Inc.) with a
modified protocol with optional on-column DNase treatment, as de-
scribed previously (54). RNA was additionally treated with Turbo DNA-
free using the manufacturer’s directions (Life Technologies, Inc.).
Purified RNA was converted to cDNA using an iScript cDNA synthesis
kit and following the manufacturer’s directions (Bio-Rad, Inc.). cDNA
was used as a template for qPCR using iTaq universal SYBR green Super-
mix (Bio-Rad, Inc.) on a 7500 fast real-time PCR system (Applied Biosys-
tems, Inc.). Samples were analyzed in at least duplicate, and the signal
from each treatment (PCA, PYO, AQDS, or MB) was first normalized to a
water-only control using the following equation: relative expression Pe
[CT(sample)  CT(control)] where Pe is the calculated efficiency for a given
primer pair. Data were then standardized to rpoA. qRT-PCR primers are
listed in Table S2 in the supplemental material.
For RNA-Seq, RNA was extracted after a 20-min exposure to 200 M
PCA, PYO, or water. rRNA was depleted with the magnetic RiboZero kit
for Gram-negative bacteria (Epicentre). A library was prepared using the
NEBNext mRNA library prep master mix set for Illumina (NEB). Se-
quencing was performed at the Millard and Muriel Jacobs Genetics and
Genomics Laboratory at the California Institute of Technology to a depth
of 12 to 15 million reads on an Illumina HiSeq2500 and processed using
the Illumina HiSeq control software (HCS version 2.0). Low-quality bases
were removed using Trimmomatic (LEADING:27 TRAILING:27 SLID-
INGWINDOW:4:20 MINLEN:35) (55), mapped using Bowtie (56), and
sorted with SAMtools (57). The number of reads per locus was calculated
with easyRNAseq (58). The .gff file was generated using the RAST anno-
tations (27, 28). Reads were normalized by number and compared to the
water control. RNA-Seq results can be found in Dataset S1 in the supple-
mental material.
Generation of mutants. M. fortuitum ATCC 6841 was used for mu-
tagenesis using a recombineering protocol (34, 59, 60). Plasmids and
primers are listed in Table S2 in the supplemental material. M. fortuitum
ATCC 6841 was electroporated with pJV53 using a protocol established
for M. smegmatis to make a recombineering strain (34, 59). Cultures were
plated on LB plates with 100g ml1 kanamycin and allowed to grow for
3 to 5 days. M. fortuitum ATCC 6841 pJV53 was grown overnight in
LB-Tw to an OD600 of 0.5 to 1, induced for 3 h with 0.2% acetamide,
washed and suspended in 10% glycerol as described previously, and fro-
zen at80°C (34).
Linear DNA constructs for generating allele replacement mutants
were generated by PCR amplifying genomic regions flanking the target
gene and the gentamicin resistance cassette from pMQ30 (61). PCR prod-
ucts were treated with XbaI and NotI (New England Biolabs) when nec-
essary (see Table S2 in the supplemental material) and T4 ligase (Invitro-
gen). Constructs were PCR amplified and electroporated into acetamide
induced M. fortuitum ATCC 6841 pJV53 and outgrown overnight in
LB-Tw medium at 30°C. Allele replacement mutants were selected on LB
plates with 100g ml1 gentamicin at 30°C. The position of the gentami-
cin cassette on the chromosome of single-gene-deletion mutants was con-
firmed by PCR and sequencing.
To complement mutations in trans, cultures were cured of pJV53 by
daily passage at 37°C for 5 days and streak purified. Colonies that had lost
pJV53 and by extension kanamycin resistance were identified by patch
plating on LB and on LB supplemented with kanamycin. Mutants cured of
pJV53 were subsequently transformed with plasmid pSD5 (60) bearing
the appropriate gene to complement the mutation.
Nucleotide sequence accession number. The complete genome se-
quence of strain CT6 has been deposited in GenBank (accession number
CP011269).
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